Lack of reactivity of anti angiotensin ii aii monoclonal antibodies mab with nonpeptide aii receptor antagonists towards a dual binding site hypothesis

Lack of reactivity of anti angiotensin ii aii monoclonal antibodies mab with nonpeptide aii receptor antagonists and cgp42112a towards a dual binding site hypothesis. European Journal of Clinical Investigation 22(4 PART 2): A3, 1992

Anti-angiotensin antibodies cross-reactive with nonpeptide angiotensin antagonists as angiotensin receptor model. Regulatory Peptides. 44(2): 239-247, 1993

Monoclonal antibodies and nonpeptide antagonists to angiotensin II. Potential implications. Hypertension 14(5): 498-500, 1989

Antihypertensive effect of a nonpeptide angiotensin ii receptor antagonists in renal hypertensive rats pretreated with a monoclonal angiotensin ii antibody. Circulation 84(4 SUPPL 2): II51, 1991

Thyroglobulin monoclonal antibody cross-reacting with thyroperoxidase induces in syngeneic mice anti-idiotypic monoclonal antibodies with dual autoantigen binding properties. The intertope hypothesis. European Journal of Immunology 29(5): 1626-1634, 1999

Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats. Clinical and Experimental Hypertension 18(2): 189-200, 1996

Rheumatoid factor autoantibody-binding site: a molecular analysis using monoclonal antibodies with dual anti-TNP and anti-IgG activities. European Journal of Immunology 19(11): 2123-2130, 1989

Lack of inter animal cross reaction of anti acetyl choline receptor antibodies at the receptor binding site as demonstrated by heterologous anti idiotype anti sera implications for immuno therapy of myasthenia gravis. Clinical & Experimental Immunology 47(1): 119-126, 1982

Monoclonal antibodies to the nonpeptide angiotensin II receptor antagonist, losartan. European Journal of Pharmacology 226(2): 179-182, 1992

Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists. Journal of Medicinal Chemistry 36(12): 1735-1745, 1993

Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site. Journal of Pharmacology and Experimental Therapeutics 274(3): 1129-1134, 1995

Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies. Molecular Pharmacology 41(6): 1081-1088, 1992

Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding. Journal of Immunology 140(1): 62-68, 1988

Nonpeptide angiotensin ii receptor antagonists insurmountable angiotensin ii antagonism of exp 3892 is reversed by the surmountable antagonists dup 753. Journal of Pharmacology & Experimental Therapeutics 258(1): 49-57, 1991

Balanced affinity AT1/AT2 receptor nonpeptide binding site determinants on the AT1 angiotensin receptor. International Journal of Molecular Medicine 2(2): 197-201, 1998